NADH-2 cytochrome C reductase and cytochrome C oxidase in experimental muscle disorders.
D000818:Animals; D003714:Denervation; D003576:Electron Transport Complex IV / Q000378:metabolism*; D004586:Electrophoresis; D066298:In Vitro Techniques; D009124:Muscle Proteins / Q000378:metabolism; D009132:Muscles / Q000201:enzymology*; D009135:Muscular Diseases / Q000378:metabolism*; D009136:Muscular Dystrophies / Q000378:metabolism*; D010088:Oxidoreductases / Q000378:metabolism*; D011817:Rabbits; D012584:Sciatic Nerve; D013217:Starvation; D013347:Subcellular Fractions; D013974:Thyroxine / Q000494:pharmacology; D014810:Vitamin E / Q000627:therapeutic use; D014811:Vitamin E Deficiency / Q000378:metabolism*; D014812:Vitamin K / Q000627:therapeutic use
D009124:Muscle Proteins; D014812:Vitamin K; D014810:Vitamin E; D010088:Oxidoreductases; D003576:Electron Transport Complex IV; D013974:Thyroxine